Doga Doraisamy
Head of Investor Relations
Replay available
Koninklijke Philips N.V. NY Registry Shares (NYSE: PHG) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

Head of Investor Relations
Chief Executive Officer
Chief Financial Officer
Analyst, Goldman Sachs
Analyst, JP Morgan
Analyst, Citi
Analyst, Barclays
Analyst, UBS
Analyst, Morgan Stanley
Analyst, BNP Paribas
Analyst, ABN Oddo
Analyst, HSBC
Analyst, Bernstein
Analyst, Jefferies
Analyst, Bank of America
Analyst
Welcome to the Royal Philips First Quarter 2025 Results Conference Call on Tuesday, May 6, 2025. During the call hosted by Mr. Roy Jacobs, CEO, and Ms. Charlotte Hanneman, CFO, all participants will be in a discerning mode. After the introduction, there will be an opportunity to ask questions. Please note that this call will be recorded and replay will be available on the Investor Relations website of Royal Philips. I'll now hand the conference over to Ms. Doga Doraisamy, Head of Investor Relations. Thank you. Please go ahead, ma'am. Hello, everyone. Welcome to Philips Results webcast for the first quarter of 2025. I'm here with our CEO, Roy Jacobs, and our CFO, Charlotte Hanneman. The press release and the investor presentation were published on our Investor Relations website this morning. The replay and full transcript of this webcast will be made available on the website after this call. Before we start, I want to draw your attention to our safe harbor statement on screen. You will also find the statement in the presentation published on our investor relations website. I will now hand it over to Roy. Good morning, everyone. Thank you for joining our results call for the first quarter of 2025. I'll walk you through our Q1 performance and the macro trends shaping our 2025 outlook. I know tariffs are top of mind and we will address them shortly. Our CFO, Charlotte Hahnemann, will then provide more detail on the quarter and full year guidance, and we will close with Q&A. I want to start with the key highlights of this morning's press release. Order intake grew. Despite a double-digit decline in China, driven by double digit order intake growth in North America and strength in diagnosis and treatment. We exited the quarter with momentum, even against the backdrop of in...